Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by GrahamBon Aug 30, 2023 3:55am
69 Views
Post# 35611293

RE:RE:VPTs Financials

RE:RE:VPTs Financials
WalkOverTheStrt wrote: Graham that is standard boiler plate verbiage most micro caps use in their filings....
We know sales are an issue but if you joined one of the investor calls Alvira has stated when they expect those POs/units to be accepted and the sales orders will ramp (Q4). I am not expecting anything of note until Q4. But if Q4 does not have a marketable (10-15+ sales) I will be concerned but again this was stated to occur two investor calls ago by Alvira. Do you join the investor calls?

I read the transcript.
the fact remains, sales are negligible and have been negligible for the history of the company.
this is a fact, verifiable.
The boiler plate, is a statement of going concern  indicating that because there have been so little sold, and because sales are uncertain, the company very well could (and has ) become insolvent.
That is also a fact.Its also a legal requirement fo companies at risk of insolvency to protect investors, notwithstanding the reassurances of bagholders and those with a vested interest.

Now loooking forward, yes, sales MAY come, and the LONG sales cycle is well known.
Still, a cash raise and dilution is also likely, and I will believe that sales will happen when I see it.]So far its just doctors with free product, paid representatives, PR firms, and promoters talking about how great the product is.

Show me the money.
<< Previous
Bullboard Posts
Next >>